Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Fisher

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|October 29, 2014
Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutationsYun Bai, Jae-Young Kim, January M Watters, et al.
Infectious Agents and Cancer|October 21, 2015
Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinomaShalaka S Hampras, Angelika Michel, Markus Schmitt, et al.
The International Journal on Drug Policy|June 10, 2025
Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs: A five-year retrospective program evaluationCarly Mallise, Danika Tremain, Maya Lindsay, et al.
The Journal of Biological Chemistry|March 16, 2019
Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomersHeledd H Jarosz-Griffiths, Nicola J Corbett, Helen A Rowland, et al.
Leukemia & Lymphoma|July 19, 2016
Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomideDana E Rollison, Rami Komrokji, Ji-Hyun Lee, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Brain : a Journal of Neurology|May 3, 2014
Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlationEline M Hamilton, Emiel Polder, Adeline Vanderver, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse PopulationsEdward Seijo, Diana Lima, Egiebade Iriabho, et al.
Plos One|January 22, 2015
A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreasJennifer Permuth-Wey, Y Ann Chen, Kate Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET TrialStephen Johnston, Shannon Puhalla, Duncan Wheatley, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|October 29, 2014
Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutationsYun Bai, Jae-Young Kim, January M Watters, et al.
Infectious Agents and Cancer|October 21, 2015
Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinomaShalaka S Hampras, Angelika Michel, Markus Schmitt, et al.
The International Journal on Drug Policy|June 10, 2025
Effectiveness of periodic incentives on clinic attendance and hepatitis C testing and treatment for people who inject drugs: A five-year retrospective program evaluationCarly Mallise, Danika Tremain, Maya Lindsay, et al.
The Journal of Biological Chemistry|March 16, 2019
Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomersHeledd H Jarosz-Griffiths, Nicola J Corbett, Helen A Rowland, et al.
Leukemia & Lymphoma|July 19, 2016
Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomideDana E Rollison, Rami Komrokji, Ji-Hyun Lee, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Brain : a Journal of Neurology|May 3, 2014
Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlationEline M Hamilton, Emiel Polder, Adeline Vanderver, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse PopulationsEdward Seijo, Diana Lima, Egiebade Iriabho, et al.
Plos One|January 22, 2015
A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreasJennifer Permuth-Wey, Y Ann Chen, Kate Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET TrialStephen Johnston, Shannon Puhalla, Duncan Wheatley, et al.
Pageof 5